Share Price and Basic Stock Data
Last Updated: November 7, 2025, 7:38 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Hindustan Organic Chemicals Ltd (HOCL), operating in the organic chemicals sector, particularly benzene-based products, has shown fluctuating revenue trends over recent quarters. The company reported sales of ₹124.40 Cr in June 2022, which rose to ₹193.84 Cr by March 2023. However, it subsequently recorded a decline to ₹145.46 Cr in June 2023, before rebounding to ₹188.73 Cr in September 2023. The trailing twelve months (TTM) revenue stood at ₹640 Cr, indicating a notable drop from ₹704 Cr recorded for FY 2024. This decline reflects challenges in maintaining consistent demand and operational efficiency amidst market volatility. The most recent quarterly sales for June 2025 recorded at ₹163.89 Cr suggest a potential recovery trend, although the overall revenue trajectory remains under scrutiny. HOCL’s ability to navigate these fluctuations will be critical for its long-term sustainability in the competitive chemical industry.
Profitability and Efficiency Metrics
HOCL’s profitability metrics reveal significant challenges, particularly in operating profit margins (OPM), which stood at -8.19%. This negative OPM indicates that the company has not been able to cover its operational expenses effectively. The operating profit fluctuated sharply, reaching a high of ₹16.44 Cr in March 2023 but later declining to -₹36.75 Cr by March 2025. The net profit, which was reported at ₹421 Cr, includes a notable spike in profits for March 2025 at ₹519.93 Cr, contrasting sharply with the previous quarters where losses were common. The interest coverage ratio (ICR) was recorded at -1.48x, indicating that HOCL is not generating sufficient earnings to cover its interest obligations, posing a risk to its financial health. Efficiency metrics such as cash conversion cycle (CCC) stood at 24 days, which is relatively favorable compared to industry standards, suggesting some operational efficiency in managing working capital.
Balance Sheet Strength and Financial Ratios
HOCL’s balance sheet reflects a complex financial structure marked by significant borrowings of ₹219 Cr against reserves of ₹978 Cr, indicating a manageable level of debt compared to its reserves. The company’s current ratio stood at 3.61, showcasing strong liquidity and the ability to meet short-term obligations. However, the total debt-to-equity ratio was recorded at 0.19, which is low compared to typical industry standards, suggesting a conservative approach to leveraging. The price-to-book value ratio (P/BV) at 0.27x indicates that the stock is undervalued relative to its book value, which could attract potential investors. Nonetheless, the return on equity (ROE) reported at 21.6% is commendable, reflecting effective use of shareholder equity to generate profits, although a declining trend in return on capital employed (ROCE) at -5% raises concerns about capital efficiency.
Shareholding Pattern and Investor Confidence
HOCL’s shareholding pattern reveals a strong promoter holding of 58.78%, suggesting significant insider confidence in the company’s long-term prospects. This stable ownership structure can be viewed positively as it may provide a buffer against volatility in market perceptions. Institutional investor participation is minimal, with domestic institutional investors (DIIs) holding only 0.02%, indicating a lack of confidence or interest from larger institutional players. The total number of shareholders has seen an increase, standing at 61,587, which may reflect growing interest from retail investors despite the company’s financial challenges. The public shareholding has remained relatively stable, fluctuating between 41.19% and 41.22% over recent quarters, indicating a steady base of retail investors. This pattern suggests that while institutional interest may be lacking, retail confidence remains resilient, which can be crucial for stock price stability.
Outlook, Risks, and Final Insight
Looking ahead, HOCL faces both opportunities and risks that will shape its future. The recent spike in net profit indicates potential for recovery, yet the volatility in operational performance and negative profit margins pose significant risks. The company must focus on improving operational efficiency and managing costs to stabilize its profit margins. Additionally, external factors such as fluctuating raw material prices and regulatory changes in the chemical industry could impact profitability. On the positive side, if HOCL can leverage its strong balance sheet and low debt levels to invest in growth initiatives, it may enhance operational capabilities and revenue generation. The ongoing commitment from promoters and the growing base of retail investors could provide a supportive backdrop for the company’s strategic endeavors. Ultimately, HOCL’s ability to navigate these challenges effectively will be crucial in determining its market position and overall financial health in the coming years.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Hindustan Organic Chemicals Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Organic Chemicals Ltd | 217 Cr. | 32.4 | 46.9/22.4 | 156 | 0.00 % | 5.20 % | 21.6 % | 10.0 | |
| Vinati Organics Ltd | 17,037 Cr. | 1,644 | 2,040/1,412 | 36.6 | 287 | 0.46 % | 20.6 % | 15.8 % | 1.00 |
| Seya Industries Ltd | 63.7 Cr. | 24.0 | 32.8/12.6 | 309 | 0.00 % | 0.51 % | 0.77 % | 10.0 | |
| Industry Average | 8,627.00 Cr | 566.80 | 36.60 | 250.67 | 0.15% | 8.77% | 12.72% | 7.00 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 124.40 | 139.36 | 173.84 | 193.84 | 145.46 | 188.73 | 186.82 | 182.87 | 59.36 | 174.72 | 165.16 | 136.62 | 163.89 |
| Expenses | 125.19 | 156.63 | 172.90 | 177.40 | 154.42 | 177.26 | 189.97 | 183.42 | 82.88 | 174.67 | 191.07 | 173.37 | 177.31 |
| Operating Profit | -0.79 | -17.27 | 0.94 | 16.44 | -8.96 | 11.47 | -3.15 | -0.55 | -23.52 | 0.05 | -25.91 | -36.75 | -13.42 |
| OPM % | -0.64% | -12.39% | 0.54% | 8.48% | -6.16% | 6.08% | -1.69% | -0.30% | -39.62% | 0.03% | -15.69% | -26.90% | -8.19% |
| Other Income | 2.49 | 8.99 | 2.62 | -4.67 | 3.21 | 4.70 | 3.53 | 6.68 | 4.64 | 5.05 | -34.53 | 550.76 | 12.62 |
| Interest | 16.18 | 12.66 | 16.95 | 17.11 | 16.97 | 17.45 | 17.68 | 17.48 | 16.05 | 18.15 | 18.26 | -9.60 | 4.98 |
| Depreciation | 0.29 | 0.30 | 0.30 | 0.30 | 0.31 | 0.36 | 0.37 | 0.39 | 0.38 | 0.45 | 0.46 | 0.35 | 0.44 |
| Profit before tax | -14.77 | -21.24 | -13.69 | -5.64 | -23.03 | -1.64 | -17.67 | -11.74 | -35.31 | -13.50 | -79.16 | 523.26 | -6.22 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.64% | 0.00% |
| Net Profit | -14.77 | -21.24 | -13.69 | -5.64 | -23.04 | -1.65 | -17.67 | -11.74 | -35.31 | -13.51 | -79.16 | 519.93 | -6.22 |
| EPS in Rs | -2.15 | -3.12 | -2.01 | -0.63 | -3.44 | -0.21 | -2.65 | -1.77 | -5.27 | -2.03 | -11.76 | 77.39 | -0.94 |
Last Updated: August 19, 2025, 1:45 pm
Below is a detailed analysis of the quarterly data for Hindustan Organic Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 163.89 Cr.. The value appears strong and on an upward trend. It has increased from 136.62 Cr. (Mar 2025) to 163.89 Cr., marking an increase of 27.27 Cr..
- For Expenses, as of Jun 2025, the value is 177.31 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 173.37 Cr. (Mar 2025) to 177.31 Cr., marking an increase of 3.94 Cr..
- For Operating Profit, as of Jun 2025, the value is -13.42 Cr.. The value appears strong and on an upward trend. It has increased from -36.75 Cr. (Mar 2025) to -13.42 Cr., marking an increase of 23.33 Cr..
- For OPM %, as of Jun 2025, the value is -8.19%. The value appears strong and on an upward trend. It has increased from -26.90% (Mar 2025) to -8.19%, marking an increase of 18.71%.
- For Other Income, as of Jun 2025, the value is 12.62 Cr.. The value appears to be declining and may need further review. It has decreased from 550.76 Cr. (Mar 2025) to 12.62 Cr., marking a decrease of 538.14 Cr..
- For Interest, as of Jun 2025, the value is 4.98 Cr.. The value appears to be increasing, which may not be favorable. It has increased from -9.60 Cr. (Mar 2025) to 4.98 Cr., marking an increase of 14.58 Cr..
- For Depreciation, as of Jun 2025, the value is 0.44 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.35 Cr. (Mar 2025) to 0.44 Cr., marking an increase of 0.09 Cr..
- For Profit before tax, as of Jun 2025, the value is -6.22 Cr.. The value appears to be declining and may need further review. It has decreased from 523.26 Cr. (Mar 2025) to -6.22 Cr., marking a decrease of 529.48 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be improving (decreasing) as expected. It has decreased from 0.64% (Mar 2025) to 0.00%, marking a decrease of 0.64%.
- For Net Profit, as of Jun 2025, the value is -6.22 Cr.. The value appears to be declining and may need further review. It has decreased from 519.93 Cr. (Mar 2025) to -6.22 Cr., marking a decrease of 526.15 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.94. The value appears to be declining and may need further review. It has decreased from 77.39 (Mar 2025) to -0.94, marking a decrease of 78.33.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 12:57 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 236 | 178 | 143 | 176 | 275 | 503 | 325 | 407 | 434 | 631 | 704 | 536 | 640 |
| Expenses | 382 | 306 | 265 | 335 | 442 | 475 | 384 | 381 | 433 | 625 | 705 | 622 | 716 |
| Operating Profit | -146 | -129 | -121 | -159 | -167 | 28 | -58 | 27 | 1 | 6 | -1 | -86 | -76 |
| OPM % | -62% | -72% | -85% | -90% | -61% | 6% | -18% | 7% | 0% | 1% | -0% | -16% | -12% |
| Other Income | 6 | -26 | 15 | 6 | 63 | 117 | 21 | 21 | 34 | 6 | 18 | 526 | 534 |
| Interest | 43 | 53 | 69 | 98 | 78 | 68 | 58 | 54 | 66 | 67 | 70 | 43 | 32 |
| Depreciation | 19 | 10 | 10 | 9 | 6 | 3 | 3 | 3 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | -202 | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 395 | 424 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 1% | |
| Net Profit | -202 | -217 | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -55 | -54 | 392 | 421 |
| EPS in Rs | -28.41 | -32.07 | -26.82 | -38.37 | -27.79 | 10.79 | -14.33 | 0.38 | -4.41 | -7.95 | -8.13 | 58.32 | 62.66 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -7.43% | 14.75% | -40.00% | 27.80% | 139.04% | -234.25% | 91.84% | -300.00% | -71.88% | 1.82% | 825.93% |
| Change in YoY Net Profit Growth (%) | 0.00% | 22.17% | -54.75% | 67.80% | 111.24% | -373.28% | 326.08% | -391.84% | 228.12% | 73.69% | 824.11% |
Hindustan Organic Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
No data available for the compounded sales growth chart.
Balance Sheet
Last Updated: September 10, 2025, 3:52 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 | 67 |
| Reserves | -707 | -933 | -1,121 | 52 | -33 | 44 | -50 | -36 | -72 | -118 | -119 | 978 |
| Borrowings | 556 | 698 | 703 | 603 | 609 | 606 | 521 | 518 | 1,226 | 1,286 | 1,362 | 219 |
| Other Liabilities | 412 | 459 | 584 | 1,103 | 1,018 | 837 | 841 | 895 | 258 | 242 | 264 | 304 |
| Total Liabilities | 329 | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,568 |
| Fixed Assets | 151 | 137 | 125 | 1,689 | 154 | 170 | 174 | 136 | 155 | 165 | 226 | 227 |
| CWIP | 38 | 11 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 140 | 143 | 104 | 131 | 1,508 | 1,384 | 1,204 | 1,309 | 1,324 | 1,313 | 1,349 | 1,336 |
| Total Assets | 329 | 292 | 234 | 1,825 | 1,662 | 1,555 | 1,379 | 1,444 | 1,479 | 1,478 | 1,575 | 1,568 |
Below is a detailed analysis of the balance sheet data for Hindustan Organic Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 67.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 67.00 Cr..
- For Reserves, as of Mar 2025, the value is 978.00 Cr.. The value appears strong and on an upward trend. It has increased from -119.00 Cr. (Mar 2024) to 978.00 Cr., marking an increase of 1,097.00 Cr..
- For Borrowings, as of Mar 2025, the value is 219.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 1,362.00 Cr. (Mar 2024) to 219.00 Cr., marking a decrease of 1,143.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 304.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 264.00 Cr. (Mar 2024) to 304.00 Cr., marking an increase of 40.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 1,568.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,575.00 Cr. (Mar 2024) to 1,568.00 Cr., marking a decrease of 7.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 227.00 Cr.. The value appears strong and on an upward trend. It has increased from 226.00 Cr. (Mar 2024) to 227.00 Cr., marking an increase of 1.00 Cr..
- For CWIP, as of Mar 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to 4.00 Cr., marking an increase of 4.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 1,336.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,349.00 Cr. (Mar 2024) to 1,336.00 Cr., marking a decrease of 13.00 Cr..
- For Total Assets, as of Mar 2025, the value is 1,568.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,575.00 Cr. (Mar 2024) to 1,568.00 Cr., marking a decrease of 7.00 Cr..
Notably, the Reserves (978.00 Cr.) exceed the Borrowings (219.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -702.00 | -827.00 | -824.00 | -762.00 | -776.00 | -578.00 | -579.00 | -491.00 | 0.00 | 5.00 | -2.00 | -305.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 18 | 51 | 22 | 19 | 11 | 17 | 14 | 3 | 7 | 11 | 10 | 15 |
| Inventory Days | 150 | 208 | 230 | 319 | 176 | 74 | 95 | 103 | 111 | 44 | 53 | 52 |
| Days Payable | 317 | 406 | 733 | 941 | 477 | 133 | 66 | 30 | 58 | 34 | 50 | 42 |
| Cash Conversion Cycle | -149 | -146 | -481 | -604 | -291 | -43 | 43 | 76 | 60 | 21 | 13 | 24 |
| Working Capital Days | -534 | -744 | -1,311 | -2,729 | 330 | 235 | 79 | -15 | -134 | -159 | -199 | 483 |
| ROCE % | -91% | -17% | 16% | -7% | 9% | 4% | 1% | 1% | -5% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 58.33 | -8.05 | -8.24 | -4.37 | -1.31 |
| Diluted EPS (Rs.) | 58.33 | -8.05 | -8.24 | -4.37 | -1.31 |
| Cash EPS (Rs.) | 58.51 | -7.83 | -8.05 | -4.19 | -0.87 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 155.40 | -13.00 | -12.77 | -5.38 | -0.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 155.40 | -13.00 | -12.77 | -5.38 | -0.10 |
| Revenue From Operations / Share (Rs.) | 79.66 | 104.64 | 93.87 | 64.47 | 61.70 |
| PBDIT / Share (Rs.) | -9.42 | 2.33 | 1.90 | 3.45 | 7.10 |
| PBIT / Share (Rs.) | -9.67 | 2.12 | 1.72 | 3.28 | 6.67 |
| PBT / Share (Rs.) | 58.70 | -8.22 | -8.23 | -4.37 | -1.30 |
| Net Profit / Share (Rs.) | 58.27 | -8.04 | -8.23 | -4.37 | -1.30 |
| NP After MI And SOA / Share (Rs.) | 58.24 | -8.12 | -7.89 | -3.97 | -1.61 |
| PBDIT Margin (%) | -11.82 | 2.22 | 2.02 | 5.35 | 11.50 |
| PBIT Margin (%) | -12.13 | 2.02 | 1.83 | 5.08 | 10.80 |
| PBT Margin (%) | 73.68 | -7.85 | -8.76 | -6.77 | -2.11 |
| Net Profit Margin (%) | 73.14 | -7.68 | -8.76 | -6.77 | -2.11 |
| NP After MI And SOA Margin (%) | 73.11 | -7.76 | -8.41 | -6.15 | -2.60 |
| Return on Networth / Equity (%) | 37.47 | 0.00 | 0.00 | 0.00 | -34.97 |
| Return on Capital Employeed (%) | -5.43 | 14.22 | 11.03 | 13.99 | 16.73 |
| Return On Assets (%) | 25.04 | -3.47 | -3.56 | -1.81 | -0.75 |
| Long Term Debt / Equity (X) | 0.00 | -0.04 | 0.00 | 0.00 | 2.49 |
| Total Debt / Equity (X) | 0.19 | -16.20 | -16.51 | -197.52 | 13.60 |
| Asset Turnover Ratio (%) | 0.34 | 0.45 | 0.42 | 0.29 | 0.29 |
| Current Ratio (X) | 3.61 | 0.91 | 0.95 | 0.99 | 1.11 |
| Quick Ratio (X) | 3.46 | 0.86 | 0.91 | 0.94 | 1.06 |
| Inventory Turnover Ratio (X) | 6.84 | 8.48 | 6.77 | 4.34 | 3.97 |
| Interest Coverage Ratio (X) | -1.48 | 0.22 | 0.19 | 0.45 | 0.89 |
| Interest Coverage Ratio (Post Tax) (X) | -1.59 | 0.20 | 0.17 | 0.42 | 0.83 |
| Enterprise Value (Cr.) | 201.55 | 807.36 | 730.02 | 377.91 | 507.33 |
| EV / Net Operating Revenue (X) | 0.37 | 1.15 | 1.16 | 0.87 | 1.22 |
| EV / EBITDA (X) | -3.18 | 51.44 | 57.21 | 16.27 | 10.63 |
| MarketCap / Net Operating Revenue (X) | 0.53 | 0.37 | 0.23 | 0.43 | 0.64 |
| Price / BV (X) | 0.27 | -5.13 | -3.05 | -102.76 | 8.62 |
| Price / Net Operating Revenue (X) | 0.53 | 0.37 | 0.23 | 0.43 | 0.64 |
| EarningsYield | 1.37 | -0.20 | -0.35 | -0.14 | -0.04 |
After reviewing the key financial ratios for Hindustan Organic Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 58.33. This value is within the healthy range. It has increased from -8.05 (Mar 24) to 58.33, marking an increase of 66.38.
- For Diluted EPS (Rs.), as of Mar 25, the value is 58.33. This value is within the healthy range. It has increased from -8.05 (Mar 24) to 58.33, marking an increase of 66.38.
- For Cash EPS (Rs.), as of Mar 25, the value is 58.51. This value is within the healthy range. It has increased from -7.83 (Mar 24) to 58.51, marking an increase of 66.34.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 155.40. It has increased from -13.00 (Mar 24) to 155.40, marking an increase of 168.40.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 155.40. It has increased from -13.00 (Mar 24) to 155.40, marking an increase of 168.40.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 79.66. It has decreased from 104.64 (Mar 24) to 79.66, marking a decrease of 24.98.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -9.42. This value is below the healthy minimum of 2. It has decreased from 2.33 (Mar 24) to -9.42, marking a decrease of 11.75.
- For PBIT / Share (Rs.), as of Mar 25, the value is -9.67. This value is below the healthy minimum of 0. It has decreased from 2.12 (Mar 24) to -9.67, marking a decrease of 11.79.
- For PBT / Share (Rs.), as of Mar 25, the value is 58.70. This value is within the healthy range. It has increased from -8.22 (Mar 24) to 58.70, marking an increase of 66.92.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 58.27. This value is within the healthy range. It has increased from -8.04 (Mar 24) to 58.27, marking an increase of 66.31.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 58.24. This value is within the healthy range. It has increased from -8.12 (Mar 24) to 58.24, marking an increase of 66.36.
- For PBDIT Margin (%), as of Mar 25, the value is -11.82. This value is below the healthy minimum of 10. It has decreased from 2.22 (Mar 24) to -11.82, marking a decrease of 14.04.
- For PBIT Margin (%), as of Mar 25, the value is -12.13. This value is below the healthy minimum of 10. It has decreased from 2.02 (Mar 24) to -12.13, marking a decrease of 14.15.
- For PBT Margin (%), as of Mar 25, the value is 73.68. This value is within the healthy range. It has increased from -7.85 (Mar 24) to 73.68, marking an increase of 81.53.
- For Net Profit Margin (%), as of Mar 25, the value is 73.14. This value exceeds the healthy maximum of 10. It has increased from -7.68 (Mar 24) to 73.14, marking an increase of 80.82.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 73.11. This value exceeds the healthy maximum of 20. It has increased from -7.76 (Mar 24) to 73.11, marking an increase of 80.87.
- For Return on Networth / Equity (%), as of Mar 25, the value is 37.47. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 37.47, marking an increase of 37.47.
- For Return on Capital Employeed (%), as of Mar 25, the value is -5.43. This value is below the healthy minimum of 10. It has decreased from 14.22 (Mar 24) to -5.43, marking a decrease of 19.65.
- For Return On Assets (%), as of Mar 25, the value is 25.04. This value is within the healthy range. It has increased from -3.47 (Mar 24) to 25.04, marking an increase of 28.51.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has increased from -0.04 (Mar 24) to 0.00, marking an increase of 0.04.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.19. This value is within the healthy range. It has increased from -16.20 (Mar 24) to 0.19, marking an increase of 16.39.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.34. It has decreased from 0.45 (Mar 24) to 0.34, marking a decrease of 0.11.
- For Current Ratio (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 3. It has increased from 0.91 (Mar 24) to 3.61, marking an increase of 2.70.
- For Quick Ratio (X), as of Mar 25, the value is 3.46. This value exceeds the healthy maximum of 2. It has increased from 0.86 (Mar 24) to 3.46, marking an increase of 2.60.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.48 (Mar 24) to 6.84, marking a decrease of 1.64.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -1.48. This value is below the healthy minimum of 3. It has decreased from 0.22 (Mar 24) to -1.48, marking a decrease of 1.70.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -1.59. This value is below the healthy minimum of 3. It has decreased from 0.20 (Mar 24) to -1.59, marking a decrease of 1.79.
- For Enterprise Value (Cr.), as of Mar 25, the value is 201.55. It has decreased from 807.36 (Mar 24) to 201.55, marking a decrease of 605.81.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.37. This value is below the healthy minimum of 1. It has decreased from 1.15 (Mar 24) to 0.37, marking a decrease of 0.78.
- For EV / EBITDA (X), as of Mar 25, the value is -3.18. This value is below the healthy minimum of 5. It has decreased from 51.44 (Mar 24) to -3.18, marking a decrease of 54.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.53, marking an increase of 0.16.
- For Price / BV (X), as of Mar 25, the value is 0.27. This value is below the healthy minimum of 1. It has increased from -5.13 (Mar 24) to 0.27, marking an increase of 5.40.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.53. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 24) to 0.53, marking an increase of 0.16.
- For EarningsYield, as of Mar 25, the value is 1.37. This value is below the healthy minimum of 5. It has increased from -0.20 (Mar 24) to 1.37, marking an increase of 1.57.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Hindustan Organic Chemicals Ltd:
- Net Profit Margin: 73.14%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -5.43% (Industry Average ROCE: 8.77%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 37.47% (Industry Average ROE: 12.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -1.59
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.46
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 36.6)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.19
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 73.14%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Benzene Based | Ambalamugal PO, Ernakulam Kerala 682302 | cs@hoclindia.com http://www.hoclindia.com/ |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Yogendra Prasad Shukla | Chairman & M.D & CFO |
| Mr. Subodh Kumar | Non Official Independent Director |
| Mr. Vinay Kumar Sharma | Non Official Independent Director |
| Mr. Manoj Sethi | Government Nominee Director |
| Ms. Vandana | Government Nominee Director |
FAQ
What is the intrinsic value of Hindustan Organic Chemicals Ltd?
Hindustan Organic Chemicals Ltd's intrinsic value (as of 08 November 2025) is 412.44 which is 1172.96% higher the current market price of 32.40, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 217 Cr. market cap, FY2025-2026 high/low of 46.9/22.4, reserves of ₹978 Cr, and liabilities of 1,568 Cr.
What is the Market Cap of Hindustan Organic Chemicals Ltd?
The Market Cap of Hindustan Organic Chemicals Ltd is 217 Cr..
What is the current Stock Price of Hindustan Organic Chemicals Ltd as on 08 November 2025?
The current stock price of Hindustan Organic Chemicals Ltd as on 08 November 2025 is 32.4.
What is the High / Low of Hindustan Organic Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Hindustan Organic Chemicals Ltd stocks is 46.9/22.4.
What is the Stock P/E of Hindustan Organic Chemicals Ltd?
The Stock P/E of Hindustan Organic Chemicals Ltd is .
What is the Book Value of Hindustan Organic Chemicals Ltd?
The Book Value of Hindustan Organic Chemicals Ltd is 156.
What is the Dividend Yield of Hindustan Organic Chemicals Ltd?
The Dividend Yield of Hindustan Organic Chemicals Ltd is 0.00 %.
What is the ROCE of Hindustan Organic Chemicals Ltd?
The ROCE of Hindustan Organic Chemicals Ltd is 5.20 %.
What is the ROE of Hindustan Organic Chemicals Ltd?
The ROE of Hindustan Organic Chemicals Ltd is 21.6 %.
What is the Face Value of Hindustan Organic Chemicals Ltd?
The Face Value of Hindustan Organic Chemicals Ltd is 10.0.